166 related articles for article (PubMed ID: 29171490)
1. [Genetic and clinical predictors of treatment efficacy in depressive disorders].
Ivanets NN; Kinkulkina MA; Tikhonova YG; Izumina TA; Avdeeva TI; Morozov DI
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):55-64. PubMed ID: 29171490
[TBL] [Abstract][Full Text] [Related]
2. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter gene (5-HTTLPR) polymorphism and efficacy of selective serotonin reuptake inhibitors--do we have sufficient evidence for clinical practice.
Karlović D; Karlović D
Acta Clin Croat; 2013 Sep; 52(3):353-62. PubMed ID: 24558768
[TBL] [Abstract][Full Text] [Related]
4. The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.
Lavretsky H; Siddarth P; Kumar A; Reynolds CF
Int J Geriatr Psychiatry; 2008 Jan; 23(1):55-9. PubMed ID: 17621383
[TBL] [Abstract][Full Text] [Related]
5. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
Zhu J; Klein-Fedyshin M; Stevenson JM
Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
[TBL] [Abstract][Full Text] [Related]
6. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
7. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
[TBL] [Abstract][Full Text] [Related]
8. Moderation of antidepressant response by the serotonin transporter gene.
Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.
Smits K; Smits L; Peeters F; Schouten J; Janssen R; Smeets H; van Os J; Prins M
Int Clin Psychopharmacol; 2007 May; 22(3):137-43. PubMed ID: 17414739
[TBL] [Abstract][Full Text] [Related]
10. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
[TBL] [Abstract][Full Text] [Related]
11. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.
Kirchheiner J; Nickchen K; Sasse J; Bauer M; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Feb; 7(1):48-55. PubMed ID: 16702979
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
13. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Illi A; Poutanen O; Setälä-Soikkeli E; Kampman O; Viikki M; Huhtala H; Mononen N; Haraldsson S; Koivisto PA; Leinonen E; Lehtimäki T
Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):95-102. PubMed ID: 20640435
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
Rotberg B; Kronenberg S; Carmel M; Frisch A; Brent D; Zalsman G; Apter A; Weizman A
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):117-22. PubMed ID: 23510446
[TBL] [Abstract][Full Text] [Related]
15. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
[TBL] [Abstract][Full Text] [Related]
17. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
